Invesco Pharmaceuticals ETF (PJP)
| Assets | $248.48M |
| Expense Ratio | 0.58% |
| PE Ratio | 18.41 |
| Shares Out | n/a |
| Dividend (ttm) | $0.75 |
| Dividend Yield | 1.07% |
| Ex-Dividend Date | Sep 18, 2023 |
| Payout Ratio | 19.78% |
| 1-Year Return | -10.84% |
| Volume | 11,543 |
| Open | 69.53 |
| Previous Close | 69.59 |
| Day's Range | 69.53 - 69.78 |
| 52-Week Low | 67.75 |
| 52-Week High | 81.07 |
| Beta | n/a |
| Holdings | 28 |
| Inception Date | Jun 23, 2005 |
About PJP
Fund Home PageThe Invesco Pharmaceuticals ETF (PJP) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an index of US pharmaceutical companies selected and weighted based on various factors using a quantitative methodology. PJP was launched on Jun 23, 2005 and is issued by Invesco.
Top 10 Holdings
55.92% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 6.78% |
| Amgen Inc. | AMGN | 6.44% |
| Gilead Sciences, Inc. | GILD | 6.17% |
| Abbott Laboratories | ABT | 6.11% |
| Merck & Co., Inc. | MRK | 5.93% |
| AbbVie Inc. | ABBV | 5.84% |
| Johnson & Johnson | JNJ | 5.74% |
| Pfizer Inc. | PFE | 5.17% |
| Amphastar Pharmaceuticals, Inc. | AMPH | 3.98% |
| United Therapeutics Corporation | UTHR | 3.75% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 18, 2023 | $0.20132 | Sep 22, 2023 |
| Jun 20, 2023 | $0.17558 | Jun 23, 2023 |
| Mar 20, 2023 | $0.20242 | Mar 24, 2023 |
| Dec 19, 2022 | $0.16828 | Dec 23, 2022 |
| Sep 19, 2022 | $0.16926 | Sep 23, 2022 |
| Jun 21, 2022 | $0.20676 | Jun 30, 2022 |
News
Where to Find Value Among Pharma Stocks
Healthcare, the second-largest sector allocation in the S&P 500, is often viewed through the lens of defensive and value traits. The latter scenario is being amplified this year, as the S&P 500 Health...
Subversive Launches ETF to Focus on Mental Health
The debut highlights the lack of funds focused on the area.
3 ETFs for the Healthcare Sector's Highs
Investors looking for equities suddenly have more than a few options to consider in this mini-market rally. Whether markets have really priced in Fed action or a possible recession already or not, inv...
Big Pharma Innovation Outlook Looks Healthy
Pharmaceuticals companies, even the old, large-cap variety, are innovators in their own right. They have to be.
Economics, Patents Critical for Pharmaceuticals Innovation, Equity Prices
The S&P 500 Health Care Index is up 18% year-to-date, an admiral though not spectacular performance. While coronavirus vaccines remain a point of much discussion, pharmaceuticals stocks also fit the b...
Blue-Chip Pharmaceuticals Stocks Contend With Political Headwinds
The Invesco Dynamic Pharmaceuticals ETF (NYSEArca: PJP) is off 3.66% month-to-date, and the source of that lethargy is easy to spot: The drug price reform debate is once again gaining momentum, prompt...
Looking for Healthier Healthcare Stocks?
The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs. The Invesco Dynamic Pharmaceuticals ETF (NYSEArc...
Best Pharmaceutical ETFs for Q4 2020
The best pharmaceutical ETFs for Q4 2020 are KURE, XPH, and PJP.